Gold bars to be exempt from tariffs, White House clarifies
WESTBROOK, Maine - Synergy CHC Corp. (NASDAQ:SNYR), a health products company with a market capitalization of $19.56 million and impressive gross margins of 68.56%, announced Wednesday it has expanded its international licensing agreement with Gravity Pharma to include Turkey alongside the previously established United Arab Emirates for distribution of its FOCUSfactor brain health supplements.
The expanded agreement brings total upfront licensing revenue to $2 million, according to the company’s press release. The deal also includes additional performance-based royalties tied to product sales in both markets. According to InvestingPro data, the company generated $33.59 million in revenue over the last twelve months, with analysts expecting sales growth in the current year.
"Adding Turkey alongside the United Arab Emirates compounds our momentum and unlocks untapped growth in scalable, capital-efficient markets," said Jack Ross, CEO of Synergy CHC Corp.
The licensing model allows Synergy to market its FOCUSfactor product line, which includes brain health supplements, cognitive beverages, and energy shots, while maintaining full ownership of its intellectual property. The company stated it retains 100% ownership of the brand and global IP rights.
Synergy CHC Corp. described the arrangement as part of its "asset-light growth strategy" that enables international expansion without diverting focus from U.S. operations.
The company noted that the global brain health market is expected to exceed $20 billion by 2030, positioning the firm to potentially benefit from increasing demand for cognitive health products. Trading at a P/E ratio of 6.47 and maintaining a healthy current ratio of 1.91, Synergy CHC shows strong fundamentals. InvestingPro analysis reveals 10+ additional key metrics and insights available for subscribers, including detailed valuation analysis and growth projections.
This development follows Synergy’s recent hiring of former Coca-Cola global beverage team members, as mentioned in the company statement.
Synergy CHC Corp.’s primary brands include FOCUSfactor and Flat Tummy, a lifestyle wellness brand targeted at women.
In other recent news, Synergy CHC Corp reported a 30% increase in earnings per share for the first quarter of 2025, although net revenue saw a 13% decline year-over-year. The company’s revenue for the quarter was $8.2 million, with a gross margin rising to 75.4% from the previous year’s 72%. In a strategic move, Synergy CHC secured a $20 million term loan from ACP Agency, LLC, aimed at debt repayment and growth initiatives, with the loan due in May 2029. The loan includes an interest-only period through 2025, offering financial flexibility for the company’s growth phase. Additionally, Synergy appointed Erik Shields as Vice President of Beverage to lead the expansion of its Focus + Energy Drinks under the FOCUSfactor brand. The company is also focusing on international expansion, with plans to generate revenue in Mexico and the UAE later in 2025. These developments are part of Synergy’s broader strategy to strengthen its market position and expand its product portfolio.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.